Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment?

Journal of Clinical Psychiatry

Volumn 66, Issue 4, 2005, Pages 455-468

  Hollon, Steven D ^a   Jarrett, Robin B ^b   Nierenberg, Andrew A ^c   Thase, Michael E ^d   Trivedi, Madhukar ^b   Rush, A John ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; FAMILY THERAPY; HAMILTON SCALE; HIGH RISK PATIENT; HUMAN; INTERPERSONAL PSYCHOTHERAPY; MAJOR DEPRESSION; MARITAL THERAPY; MEDLINE; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; PSYCINFO; RELAPSE; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 17844398738     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0408     Document Type: Review

References (110)

1. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychol Sci Pub Interest 2002;3:39-77
2. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Maj M, Sartorius N, eds. WPA Series: Evidence and Experience in Psychiatry: Depressive Disorders, vol 1. Chichester, UK: Wiley; 1999: 161-206
3. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
4. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder [Revision]. Am J Psychiatry 2000;157(suppl 4):1-45
5. Friedman MA, Detweiler-Bedell JB, Leventhal HE, et al. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Prac 2004;11:47-68
6. Pampallona S, Bollini P, Tibaldi G, et al. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004;61:714-719
7. Nierenberg AA. Predictors of response to antidepressants: general principles and clinical implications. Psychiatr Clin North Am 2003;26: 345-352
8. Thase ME. How should efficacy be evaluated in randomized clinical trials of treatment for depression? J Clin Psychiatry 1999;60(suppl 4): 23-31
9. Reich JH, Green AI. Effects of personality disorders on outcome of treatment. J Nerv Ment Dis 1991;179:74-82
10. Petersen T, Hughes M, Papakostas GI, et al. Treatment-resistant depression and axis II comorbidity. Psychother Psychosom 2002;71:269-274
11. Thase ME, Kupfer DJ. Recent developments in the pharmacotherapy of mood disorders. J Consult Clin Psychol 1996;64:646-659
12. Anderson IM. Meta-analytical studies on new antidepressants. BMJ 2001;57:161-178
13. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241
14. Thase ME. The need for clinically relevant research on treatment-resistant depression [commentary]. J Clin Psychiatry 2001;62:221-224
15. Stewart JW, Garfinkel R, Nunes EV, et al. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 1998;18:429-434
16. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-1452
17. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997;58 (suppl 13):23-29
18. Agency for Health Care Policy and Research. Treatment of Depression: Newer Pharmacotherapies: Summary, Evidence Report/Technology Assessment Number 7. Rockville, Md: US Dept Health Human Services; 1999. Available at: http://www.ahcpr.gov/clinic/deprsumm.htm
19. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol 1998;66:37-52
20. Jarrett RB, Rush AJ. Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry 1994;57:115-132
21. Daneman EA. Imipramine in office management of depressive reactions: a double-blind study. Dis Nerv Syst 1961;22:213-217
22. Covi L, Lipman RS. Cognitive behavioral group psychotherapy combined with imipramine in major depression: a pilot study. Psychopharmacol Bull 1987;23:173-176
23. Covi L, Lipman RS, Derogatis LR, et al. Drugs and group psychotherapy in neurotic depression. Am J Psychiatry 1974;131:191-198
24. Hersen M, Bellack AS, Himmelhoch JM, et al. Effects of social skill training, amitriptyline, and psychotherapy in unipolar depressed women. Behav Ther 1984;15:21-40
25. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol 1979;47:818-836
26. Bumand Y, Andreoli A, Kolatte E, et al. Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatr Serv 2002;53:585-590
27. De Jonghe F, Kool S, van Aalst G, et al. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001;64: 217-229
28. De Jonghe F, Hendriksen M, van Aalst G, et al. Psychotherapy alone and combined with pharmacotherapy in the treatment of depression. Br J Psychiatry 2004;185:37-45
29. Gallagher DE, Thompson LW. Treatment of major depressive disorder in older adult outpatients with brief psychotherapies. Psychother Theory Res Pract 1982;19:482-490
30. Thompson LW, Gallagher D, Breckenridge JS. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 1987;55:385-390
31. Weissman MM, Prusoff BA, DiMascio A, et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979;136:555-558
32. DiMascio A, Weissman MM, Prusoff BA, et al. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 1979;36:1450-1456
33. Prusoff BA, Weissman MM, Klerman GL, et al. Research diagnostic criteria subtypes of depression: their role as predictors of differential response to psychotherapy and drug treatment. Arch Gen Psychiatry 1980;37:796-801
34. Weissman MM, Klerman GL, Prusoff B, et al. Depressed outpatients: results one year after treatment with drugs and/or interpersonal therapy. Arch Gen Psychiatry 1981;38:51-55
35. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-982
36. Watkins JT, Leber WR, Imber SD, et al. Temporal course of change of depression. J Consult Clin Psychol 1993;61:858-864
37. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991; 148:997-1008
38. Browne G, Steiner M, Roberts J, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002;68:317-330
39. Klerman GL, DiMascio A, Weissman M, et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-191
40. Hollon SD, DeRubeis RJ. Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug psychotherapy comparative trials. Psychol Bull 1981;90:467-477
41. Weissman MM, Klerman GL, Paykel ES, et al. Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 1974;30: 771-778
42. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47: 1093-1099
43. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent depression: a randomized controlled trial in patients older than 59 years. JAMA 1999;281: 39-45
44. Blackburn IM, Bishop S, Glen AIM, et al. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry 1981;139: 181-189
45. Rush AJ, Beck AT, Kovacs M, et al. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognit Ther Res 1977;1:17-38
46. Meterissian GB, Bradwejn J. Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided? J Clin Psychopharmacol 1989; 9:334-339
47. Murphy GE, Simons AD, Wetzel RD, et al. Cognitive therapy and pharmacotherapy, singly and together, in the treatment of depression. Arch Gen Psychiatry 1984;41:33-41
48. Hollon SD, DeRubeis RJ, Evans MD, et al. Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry 1992;49:774-781
49. Klein DF. Preventing hung juries about therapy studies. J Consult Clin Psychol 1996;64:81-87
50. Elkin I, Gibbons RD, Shea T, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1995;63:841-847
51. Jacobson NS, Hollon SD. Cognitive-behavior therapy versus pharmacotherapy: now that the jury's returned its verdict, it's time to present the rest of the evidence. J Consult Clin Psychol 1996;64:74-80
52. Jacobson NS, Hollon SD. Prospects for future comparisons between drugs and psychotherapy: lessons from the CBT-versus-pharmacotherapy exchange. J Consult Clin Psychol 1996;64:104-108
53. DeRubeis RJ, Gelfand LA, Tang TZ, et al. Medication versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry 1999;156:1007-1013
54. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. In press
55. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:431-437
56. Ravindran AV, Anisman H, Merali Z, et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry 1999;156: 1608-1617
57. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989;46:89-99
58. Kovacs M, Rush AJ, Beck AT, et al. Depressed outpatients treated with cognitive therapy or pharmacotherapy. Arch Gen Psychiatry 1981;38: 33-39
59. Gallagher DE Thompson LW. Effectiveness of psychotherapy for both endogenous and nonendogenous depression in older adult outpatients. J Gerontol 1983;38:707-712
60. Thase ME, Bowler K, Harden T. Cognitive behavior therapy of endogenous depression, pt 2: preliminary findings in 16 unmedicated inpatients. Behav Ther 1991;22:469-477
61. Simons AD, Thase ME. Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: electroencephalographic sleep studies and response to cognitive therapy. J Consult Clin Psychol 1992;60:392-401
62. Thase ME, Dube S, Bowler K, et al. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. Am J Psychiatry 1996;153:886-891
63. Thase ME, Simons AD, Reynolds CF III. Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatry 1996;53:99-108
64. Corbishley M, Beutler L, Quan S, et al. Rapid eye movement density and latency and dexamethasone suppression as predictors of treatment response in depressed older adults. Curr Ther Res 1990;47:846-859
65. McKnight DL, Nelson-Gray RO, Barnhill J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav Ther 1992;23:99-111
66. Thase ME, Reynolds CF, Frank E, et al. Do depressed men and women respond similarly to cognitive behavior therapy? Am J Psychiatry 1994; 151:500-505
67. Thase ME, Frank E, Kornstein S, et al. Gender differences in response to treatments of depression. In: Frank E, ed, Gender and Its Effects on Psychopathology. Washington, DC: American Psychiatric Press Inc; 2000:103-129
68. Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1990;147:711-718
69. Beck AT, Freeman A. Cognitive Therapy of Personality Disorders. New York, NY: Guilford Press; 1990
70. Beck J. Cognitive Therapy: Basics and Beyond. New York, NY: Guilford Press; 1995.
71. Barber JP, Muenz LR. The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the Treatment for Depression Collaborative Research Program. J Consult Clin Psychol 1996;64:951-958
72. Miller IW, Norman WH, Keitner GI. Treatment response of high cognitive dysfunction depressed inpatients. Compr Psychiatry 1990;31:62-71
73. Rude SS, Rehm LP. Response to treatments for depression: the role of initial status on targeted cognitive and behavioral skills. Clin Psychol Rev 1991;11:493-514
74. Jarrett RB, Basco MR, Riser R, et al. Is there a role for continuation phase cognitive therapy for depressed outpatients? J Consult Clin Psychol 1998;66:1036-1040
75. Jarrett RB, Kraft D, Doyle J, et al. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry 2001;58:381-388
76. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in outpatients with recurrent depression. Br J Psychiatry 1997;171:328-334
77. Blackburn IM, Eunson KM, Bishop S. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord 1986;10:67-75
78. Simons AD, Murphy GE, Levine JE, et al. Cognitive therapy and pharmacotherapy for depression: sustained improvement over one year. Arch Gen Psychiatry 1986;43:43-49
79. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992;49:802-808
80. Shea MT, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry 1992;49:782-787
81. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Arch Gen Psychiatry. In press
82. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry 1999;56:829-835
83. Teasdale JD, Segal Z, Williams JMG, et al. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615-623
84. Fava GA, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry 1998;55:816-820
85. Perlis RH, Nierenberg AA, Alpert JE, et al. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol 2002;22:474-480
86. Fava GA, Ruini C, Rafanelli C, et al. Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. Am J Psychiatry 2002;159:2094-2095
87. Fava GA, Ruini C, Sonino N. Management of recurrent depression in primary care. Psychother Psychosom 2003;72:3-9
88. Fabbri S. Family intervention approach to loss of clinical effect during antidepressant treatment [letter]. Psychother Psychosom 2004;73:124
89. Conte HR, Plutchik R, Wild KV, et al. Combined psychotherapy and pharmacotherapy for depression. Arch Gen Psychiatry 1986;43:471-479
90. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-1015
91. Bowers WA. Treatment of depressed in-patients: cognitive therapy plus medication, relaxation plus medication, and medication alone. Br J Psychiatry 1990;156:73-78
92. Miller IW, Norman WH, Keitner GI, et al. Cognitive-behavioural treatment of depressed inpatients. Behav Ther 1989;20:25-47
93. Mynors-Wallis LM, Gath DH, Day A, et al. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000;320: 26-30
94. Scott C, Tacchi MJ, Jones R, et al. Acute and one-year outcome of a randomized controlled trial of brief cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 1997;171:131-134
95. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470
96. McCullough JP. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York, NY: Guilford Press; 2000
97. Barlow DH, German JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic. JAMA 2000;283: 2529-2536
98. Jacobson NS, Dobson KS, Truax PA, et al. A component analysis of cognitive-behavior treatment for depression. J Consult Clin Psychol 1996;64:295-304
99. Jacobson NS, Martell C, Dimidjian S. Behavioral activation treatment for depression: returning to contextual roots. Clin Psychol Sci Prac 2001;8:255-270
100. Martell CR, Addis ME, Jacobson NS. Depression in Context: Strategies for Guided Action. New York, NY: Norton; 2001
101. Hollon SD. Do cognitive change strategies matter in cognitive therapy? Prevention & Treatment [serial online]. 2000;3:article 25. Available at: http://journals.apa.org/prevention/volume3/pre0030025c.html. Accessed Nov 5, 2004
102. O'Leary KD, Christian JL, Mandell NR. A closer look at the link between marital discord and depressive symptomatology. J Soc Clin Psychol 1994;13:33-41
103. McLean PD, Ogston K, Grauer L. A behavioral approach to the treatment of depression. J Behav Ther Exp Psychiatry 1973;58:482-488
104. O'Leary KD, Beach SRH. Marital therapy: a viable treatment for depression and marital discord. Am J Psychiatry 1990;174:183-186
105. Jacobson NS, Dobson KS, Fruzzetti AE, et al. Marital therapy as a treatment for depression. J Consult Clin Psychol 1991;59:547-557
106. Hooley JM, Teasdale JD. Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol 1989;98:229-235
107. Baucom DH, Shoham V, Mueser KT, et al. Empirically supported couple and family interventions for marital distress and adult mental health problems. J Consult Clin Psychol 1998;66:53-88
108. Friedman AS. Interaction of drug therapy with marital therapy in depressive patients. Arch Gen Psychiatry 1975;32:619-637
109. Craighead WE, Miklowitz DJ. Psychosocial interventions for bipolar disorder. J Clin Psychiatry 2000;61(suppl 13):58-64
110. Clarkin JF, Glick ID, Haas GL, et al. A randomized clinical trial of inpatient family intervention, 5: results for affective disorders. J Affect Disord 1990;18:17-28